Clinical Trial Update: Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating gefitinib with radiation therapy for patients with inoperable stage I or II non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: WITHDRAWN